Identification of oxidative degradation impurities of Olanzapine drug substance as well as drug product

Impurities found in stressed and stability studies of Olanzapine (polymorphic form-I) [1–7] in both drug substance and drug product are described. These impurities are identified as 4-(4-methyl-1-piperazinyl)-3-hydroxymethylidene-1 H-benzo[b][1,4]diazepine-2(3H)-thione (hydroxymethylidene thione) an...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical and biomedical analysis Vol. 56; no. 2; pp. 413 - 418
Main Authors Rao, P. Sreenivasa, Ray, Uttam Kumar, Hiriyanna, S.G., Rao, Sumathi V., Sharma, Hemant Kumar, Handa, Vijay Kumar, Mukkanti, K.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 10.09.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Impurities found in stressed and stability studies of Olanzapine (polymorphic form-I) [1–7] in both drug substance and drug product are described. These impurities are identified as 4-(4-methyl-1-piperazinyl)-3-hydroxymethylidene-1 H-benzo[b][1,4]diazepine-2(3H)-thione (hydroxymethylidene thione) and (Z)-4-(4-methyl-1-piperazinyl)-3-acetoxymethylidene-1 H-benzo[b][1,4]diazapine-2(3H)-thione (acetoxymethylidene thione). An oxidative degradation pathway of Olanzapine, for the formation of these impurities, has been proposed.
Bibliography:http://dx.doi.org/10.1016/j.jpba.2011.05.003
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0731-7085
1873-264X
DOI:10.1016/j.jpba.2011.05.003